Pseudomonas Aeruginosa Virulence and Antibiotic Resistance Mechanisms

Pseudomonas aeruginosa is a ubiquitous Gram-negative opportunist responsible for a wide spectrum of acute and chronic infections, particularly in immunocompromised individuals and patients with cystic fibrosis or indwelling devices. Its pathogenic success stems from a sophisticated arsenal of virulence determinants, including biofilm development, a versatile type III secretion system (T3SS) delivering effector toxins (ExoS, ExoU, ExoT, ExoY), potent secreted enzymes (elastase, phospholipases), siderophore-mediated iron scavenging and small-molecule exotoxins such as Exotoxin A. These factors act in concert to promote adhesion, tissue invasion, immune evasion and persistent infection. Concomitantly, P. aeruginosa exhibits intrinsic resistance to many antibiotic classes via low outer-membrane permeability, chromosomally encoded multidrug efflux pumps (MexAB-OprM, MexXY), inducible β-lactamases (AmpC) and target-modifying enzymes. Additional resistance emerges through acquisition of extended-spectrum β-lactamases, carbapenemases and aminoglycoside-modifying enzymes, as well as mutations in porin genes (oprD) or regulatory circuits that upregulate efflux. Within biofilms, cells display phenotypic tolerance to antibiotics and host defences, further complicating eradication. The global rise of multidrug-resistant (MDR) and extensively drug-resistant (XDR) P. aeruginosa strains has created an urgent need for novel therapeutic and preventive strategies, from antivirulence agents and biofilm disruptors to phage and combination regimens.

Research from Nature Portfolio

Recent studies have documented the alarming emergence of highly resistant P. aeruginosa in aquatic food chains. Investigations of isolates from fish and human handlers revealed uniform resistance to key aminoglycosides and polymyxins, with over 80 % of strains classified as MDR or XDR. These isolates carried multiple virulence-associated genes (lasB, toxA, exoU, oprL) and biofilm-related loci (pslA, pelA, lasR), often co-occurring with quorum-sensing regulators (lasI, rhlR). Experimental infections in fish models confirmed heightened mortality tied to virulence gene load, emphasising public health risks in food production. Earlier work in aquaculture settings traced the prevalence of oprL and toxA among farmed fish isolates, alongside widespread blaTEM, blaCTX-M and tetA resistance genes. Such studies underscore the zoonotic potential of MDR P. aeruginosa and the need for stringent hygiene, routine susceptibility testing and surveillance across the food supply.

Pseudomonas Aeruginosa Virulence and Antibiotic Resistance Mechanisms publication trend

The graph below shows the total number of articles in pseudomonas aeruginosa virulence and antibiotic resistance mechanisms across all publications each year (not limited to Nature Index journals).

Technical terms

Biofilm: Structured microbial community attached to surfaces and encased in a self-produced extracellular polymeric matrix, conferring tolerance to antibiotics and immune defences.

Efflux pump: Membrane protein complex that actively exports antibiotics and toxic compounds out of bacterial cells, reducing intracellular drug concentration.

Type III secretion system (T3SS): Needle-like molecular apparatus that translocates bacterial effector proteins directly into host cell cytosol to modulate host processes.

Quorum sensing: Cell-to-cell communication mechanism involving diffusible signal molecules that regulate gene expression, including virulence and biofilm formation, in a population density-dependent manner.

β-lactamase: Enzyme that hydrolyses β-lactam antibiotics (penicillins, cephalosporins), rendering them inactive and contributing to resistance.

Multidrug-resistant (MDR): Bacterial strain non-susceptible to at least one agent in three or more antimicrobial categories.

References

1. Resistance patterns, virulence determinants, and biofilm genes of multidrug-resistant Pseudomonas aeruginosa isolated from fish and fish handlers. Scientific Reports (2024).
2. Emerging MDR-Pseudomonas aeruginosa in fish commonly harbor oprL and toxA virulence genes and blaTEM, blaCTX-M, and tetA antibiotic-resistance genes. Scientific Reports (2020).
3. Comparison of Virulence-Factor-Encoding Genes and Genotype Distribution amongst Clinical Pseudomonas aeruginosa Strains. International Journal of Molecular Sciences (2023).
4. Virulence Factors of Pseudomonas Aeruginosa and Antivirulence Strategies to Combat Its Drug Resistance. Frontiers in Cellular and Infection Microbiology (2022).